Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (5326)	9/18/1998 12:46:00 PM
From: Izzy	Read Replies (2) of 6136

Rick: VRTX stock price is on the move up. Maybe Phase III clinical trials on amprenavir are being completed and FDA approval is pending. Do you (or anyone) have any info? Looks like the market is going to be flooded with additional HIV drugs, which, in many aspects, makes future clinical HIV treatment more confusing. IMO, patients should also consider taking supplemental alternative nonprescription therapies as Dr. Oliver has stated previously (it surely can't hurt any).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next